| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT07508228 A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-11 | NCT06447662 A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-11 | NCT06447662 A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other… |
Enrollment reduced: 330 -> 64 participants |
| 2026-07-11 | NCT06447662 A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other… |
date change Primary completion moved earlier: 2028-01-19 -> 2026-10-09 |
| 2026-07-11 | NCT06447662 A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other… |
date change Completion moved earlier: 2029-01-18 -> 2026-10-09 |
| 2026-07-10 | NCT06398626 An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative… |
Trial sites expanded: 22 -> 28 locations |
| 2026-07-10 | NCT03950232 An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis |
Trial sites expanded: 211 -> 470 locations |
| 2026-07-10 | NCT07653100 A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF |
Trial sites expanded: 5 -> 10 locations |
| 2026-07-10 | NCT05748171 A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in… |
Trial sites reduced: 74 -> 68 locations |
| 2026-07-10 | NCT05748171 A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in… |
date change Primary completion moved earlier: 2033-10-31 -> 2033-05-21 |
| 2026-07-10 | NCT05748171 A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in… |
date change Completion moved earlier: 2036-11-04 -> 2036-05-25 |
| 2026-07-10 | NCT07508241 A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-10 | NCT07508241 A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the… |
Enrollment increased: 20 -> 22 participants |
| 2026-07-10 | NCT06989437 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas… |
Trial sites expanded: 211 -> 214 locations |
| 2026-07-10 | NCT07573462 A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants |
Trial sites expanded: 9 -> 21 locations |
| 2026-07-10 | NCT05623020 A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and… |
Trial sites expanded: 121 -> 127 locations |
| 2026-07-10 | NCT05742217 A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are… |
Trial completed |
| 2026-07-10 | NCT05742217 A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are… |
Enrollment reduced: 250 -> 121 participants |
| 2026-07-10 | NCT07228390 A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long… |
Trial sites expanded: 54 -> 71 locations |
| 2026-07-10 | NCT07160244 BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women… |
Trial sites expanded: 202 -> 207 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-06 | NCT07685769 A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India | Phase 4 | Not Yet Recruiting |
| 2026-06-30 | NCT07677358 A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in… | Phase 1 | Not Yet Recruiting |
| 2026-06-29 | NCT07673081 Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in… | Not Yet Recruiting | |
| 2026-06-23 | NCT07663630 A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung… | Phase 1 | Not Yet Recruiting |
| 2026-06-22 | NCT07660198 Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal… | Phase 3 | Recruiting |
| 2026-06-22 | NCT07660731 A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05203172 | The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and… | Solid Tumors | Recruiting |
| NCT06952660 | Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical… | Cervical Cancer | Recruiting |
| NCT06057402 | Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) | Multiple Myeloma | Recruiting |
| NCT07609914 | A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant… | Acute Treatment of Migraine | Recruiting |
| NCT05160922 | Crizotinib Continuation Clinical Study | NSCLC | Active, Not Recruiting |
| NCT05295290 | A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are… | Myocarditis | Active, Not Recruiting |
| NCT07685769 | A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India | Acute Treatment of Migraine | Not Yet Recruiting |
| Phase 3 | |||
| NCT06807281 | A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older… | Atopic Dermatitis | Recruiting |
| NCT06758401 | This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug… | Non-Small Cell Lung Cancer | Recruiting |
| NCT07144280 | A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel… | Non-small Cell Carcinoma | Recruiting |
| NCT07029828 | A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With… | Severe Alopecia Areata | Recruiting |
| NCT05020236 | A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in… | Multiple Myeloma | Recruiting |
| NCT06807268 | A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age… | Eczema | Recruiting |
| NCT07062965 | A Study to Learn About the Study Medicine Called PF-07248144 in Combination With… | Breast Cancer | Recruiting |
| NCT07500506 | A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of… | Lyme Disease | Recruiting |
| NCT05611801 | A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A… | Hemophilia A | Recruiting |
| NCT06698796 | A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic… | Dermatomyositis | Recruiting |
| NCT07282665 | A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and… | Clostridioides Difficile Associated Disease | Recruiting |
| NCT05568719 | Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in… | Hemophilia A | Recruiting |
| NCT05895786 | A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active… | Myositis | Recruiting |
| NCT07543380 | A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High… | Respiratory Syncytial Virus (RSV) | Recruiting |
| NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in… | Colorectal Neoplasms | Recruiting |
| NCT05145127 | Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without… | Hemophilia A | Recruiting |
| NCT07222800 | Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in… | Intestinal Neoplasms | Recruiting |
| NCT07311850 | Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity | Obesity and Overweight | Recruiting |